[1] |
朱连成, 郭骞, 勾睿, 等.转染人附睾蛋白4基因对人卵巢癌细胞基因表达的影响[J].中国医科大学学报, 2020, 49(5):385. |
[2] |
张维维, 张正伟, 何朗.342例卵巢癌手术患者预后影响因素分析[J].中华肿瘤防治杂志, 2019, 26(17):1288. |
[3] |
陈丽云, 郑丽华, 罗飞, 等.炎症在卵巢癌发病中的作用研究进展[J].现代中西医结合杂志, 2015, 24(32):3646. doi: 10.3969/j.issn.1008-8849.2015.32.043 |
[4] |
胡霞, 单晶, 孙晓滨.IL-33/ST2途径在肿瘤发生和发展中作用的研究进展[J].肿瘤预防与治疗, 2019, 32(4):366. doi: 10.3969/j.issn.1674-0904.2019.04.014 |
[5] |
LI X, LV Q, FENG Y, et al.Interleukin-33, a potential cytokine expressed in tumor microenvironment involves in antitumor immunotherapy through facilitates cd8 T cells[J].J Interferon Cytokine Res, 2018, 38(11):491. doi: 10.1089/jir.2018.0069 |
[6] |
LI L, BAI H, YANG J, et al.Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities[J].Oncotarget, 2017, 8(9):15136. doi: 10.18632/oncotarget.14767 |
[7] |
GAO X, WANG XF, YANG QT, et al.Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+T and NK cells[J].J Immunol, 2015, 194(1):438. doi: 10.4049/jimmunol.1401344 |
[8] |
TRABERT B, PINTO L, HARTGE P, et al.Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer(PLCO)screening trial[J].Gynecol Oncol, 2014, 135(2):200. |
[9] |
赵薇, 徐鹏, 田亚楠, 等.白介素-33在妇科肿瘤中的研究进展[J].中华全科医学, 2020, 18(3):467. |
[10] |
TONG X, BARBOUR M, HOU K, et al.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways[J].Mol Oncol, 2016, 10(1):113. doi: 10.1016/j.molonc.2015.06.004 |
[11] |
胡霞, 孙晓滨, 单晶.IL-33及其受体ST2在食管腺癌中的表达及其对肿瘤细胞增殖、迁移与侵袭的影响[J].四川医学, 2019, 40(1):32. |
[12] |
LI Y, SHI J, QI S, et al.IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE2[J].J Exp Clin Cancer Res, 2018, 37(1):196. doi: 10.1186/s13046-018-0839-7 |
[13] |
KIM JY, LIM SC, KIM G, et al.Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity[J].Oncogene, 2015, 34(38):4928. doi: 10.1038/onc.2014.418 |
[14] |
朱熠, 黄建鸣, 张国楠.卵巢上皮性癌MyD88表达的潜在调控机制研究进展[J].中华妇产科杂志, 2019(2):139. doi: 10.3760/cma.j.issn.0529-567x.2019.02.016 |
[15] |
YU XX, HU Z, SHEN X, et al.IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway[J].Dig Dis Sci, 2015, 60(5):1265. doi: 10.1007/s10620-014-3463-1 |
[16] |
杨淑梅, 曹蕾, 秦天洁, 等.卵巢癌细胞中RhoA和NF-κB表达与癌细胞增殖、侵袭能力的关系[J].现代生物医学进展, 2018, 18(24):4628. |
[17] |
TONG X, BARBOUR M, HOU K, et al.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways[J].Mol Oncol, 2016, 10(1):113. doi: 10.1016/j.molonc.2015.06.004 |